Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene mutations can weaken the skin barrier and, when combined with environmental factors, lead to eczema and severe itching.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The testes produce sperm and hormones essential for male development.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

More effective treatments are needed for severe alopecia areata.

Thyroid and gonadal hormones control seasonal hair growth and molting in male European badgers.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

New genetic locations explain much of hair color variation in Europeans.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

A new gene, JMJD1C, may affect testosterone levels in men.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Atopic dermatitis increases the risk of some autoimmune diseases.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Identified genes linked to male-pattern baldness may help develop new treatments.

The study concluded that a new method can effectively assess scalp sun damage in balding men, which increases with age and sun exposure.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Androgenetic alopecia is common in north Anatolia, affecting more men than women.